Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 985.30
+19.30 (2.00%)
Nov 11, 2026, 1:00 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 156.16 billion as of November 10, 2026. Its market cap has decreased by 13.35% in one year.
Market Cap
156.16B
Enterprise Value
179.66B
Revenue
86.08B
Global Rank
n/a
Country Rank
n/a
PE Ratio
44.44
ChartMarket Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 156.16B, an increase of 38,292.90%. That is a compound annual growth rate of 25.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 156.16B | -8.27% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 317.59B |
| Wockhardt | 317.28B |
| Alembic Pharmaceuticals | 189.29B |
| Alivus Life Sciences | 180.71B |
| Eris Lifesciences | 171.62B |
| Cohance Lifesciences | 165.66B |
| NATCO Pharma | 158.31B |
| Sudeep Pharma | 132.83B |